Año: 2022
Journal Impact Factor (JIF): 7.70
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ENDOCRINOLOGY & METABOLISM | SCIE | 18/145 | Q1 | T1 | D2 |
Año: 2022
Journal Citation Indicator (JCI): 1,690
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ENDOCRINOLOGY & METABOLISM | 12/184 | Q1 | T1 | D1 | 93,75 |
Año:
2022
CiteScore:
12,300
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 16/232 | Q1 | T1 | D1 |
| Internal Medicine | 13/140 | Q1 | T1 | D1 |
SJR año:
2022
Factor de Impacto:
2,635
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 9/245 | Q1 | T1 | D1 |
| Internal Medicine | 12/163 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Academy of Medical Sciences | - |
| BBSRC | BB/T017929/1 |
| British Society for Neuroendocrinology | - |
| Diabetes UK grants | BDA/11/0004210; BDA/15/0005275; BDA16/0005485 |
| Diabetes UKD project grant | 16/0005485 |
| Engineering and Physical Sciences Research Council capital award | - |
| European Commission Innovative Medicines Initiative 2 Joint Undertaking | 115881 |
| European Federation for the Study of Diabetes | - |
| European Union | - |
| Experimental Challenge Grant | MR/L02036X/1 |
| Human Islet Research Network | UC4 DK104162; RRID:SCR_014393 |
| JDRF | CDA-2016-189; SRA-2018-539; COE-2019-861 |
| Medical Research Council | MR/N00275X/1; MR/R010676/1 |
| Medical Research Council Programme grants | MR/R022259/1; MR/J0003042/1; MR/L020149/1 |
| MRC | MR/R010676/1; MR/K023667/1; MR/S025618/1; MR/R022259/1; MR/N00275X/1; MR/L020149/1 |
| National Institutes of Health | R03 DK115990; R01 DK108921; U01 DK127747 |
| Society for Endocrinology | - |
| U.S. Department of Veterans Affairs | I01 BX004444 |
| Wellcome Trust | 098424AIA; 212625/Z/18/Z |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Georgiadou, E | Imperial College London Section of Cell Biology and Functional Genomics (England) |
| 2 | Muralidharan, C | Indiana University Bloomington (USA) |
| 3 | Martinez, M | Indiana University Bloomington (USA) |
| 4 | Chabosseau, P | Imperial College London Section of Cell Biology and Functional Genomics (England) |
| 5 | Akalestou, E | Imperial College London Section of Cell Biology and Functional Genomics (England) |
| 6 | Tomas, A | Imperial College London Section of Cell Biology and Functional Genomics (England) |
| 7 | Wern, FYS | Lee Kong Chian School of Medicine (Singapore) |
| 8 | Stylianides, T | Loughborough University (England) |
| 9 | Wretlind, A | Steno Diabetes Center (Denmark) |
| 10 | Legido-Quigley, C | Steno Diabetes Center; King's College London Institute of Pharmaceutical Science (England) |
| 11 | Jones, B | Imperial College London Section of Endocrinology and Investigative Medicine (England) |
| 12 | Lopez-Noriega, L | Imperial College London Section of Cell Biology and Functional Genomics (England) |
| 13 | Xu, YW | Vanderbilt University School of Medicine (USA) |
| 14 | Gu, GQ | Vanderbilt University School of Medicine (USA) |
| 15 | Alsabeeh, N | Kuwait University (Kuwait) |
| 16 | Cruciani-Guglielmacci, C | CNRS - National Institute for Biology (INSB) (France) |
| 17 | Magnan, C | CNRS - National Institute for Biology (INSB) (France) |
| 18 | Ibberson, M | Swiss Institute of Bioinformatics (Switzerland) |
| 19 | Leclerc, I | Imperial College London Section of Cell Biology and Functional Genomics (England) |
| 20 | Ali, Y | Lee Kong Chian School of Medicine (Singapore) |
| 21 | Soleimanpour, SA | University of Michigan Department of Internal Medicine; University of Michigan School of Medicine; VA Ann Arbor Healthcare System (USA) |
| 22 | Linnemann, AK | Indiana University Bloomington (USA) |
| 23 | Rodriguez, TA | National Heart and Lung Institute UK (England) |
| 24 | Lee Kong Chian School of Medicine; Université de Montréal; Imperial College London Section of Cell Biology and Functional Genomics (Singapore) |
